Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642836 · ClinicalTrials.gov registry record · NA
Clinic, Family & Community Intervention for Children With Overweight and Obesity (Stanford GOALS)
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT01642836: Completed NA study, sponsored by Stanford University.
NCT01642836 is a NA study that has completed, run by Stanford University. The registered enrollment target is 241 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01642836, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
Stanford GOALS is a large-scale, community-based randomized controlled trial of an innovative, interdisciplinary, multi-component, multi-level, multi-setting (MMM) approach to treating overweight and obese children. Primary Research Question: Will a 3-year, innovative, interdisciplinary, multi-component, multi-level, multi-setting (MMM) community-based intervention to treat overweight and obese children significantly reduce BMI compared to an enhanced standard care/health and nutrition education active comparison intervention?
Primary Outcome
slope of measured weight in kilograms divided by the square of height in meters
Interventions
- BEHAVIORAL MMM
- BEHAVIORAL Health and Nutrition Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2012-07-13 |
| Est. Completion | 2016-12-19 |
| Phase | NA |
What the finished NCT01642836 record still lists
NCT01642836 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which MMM is the first listed.
NCT01642836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01642836 about?
NCT01642836 is a clinical study titled "Clinic, Family & Community Intervention for Children With Overweight and Obesity (Stanford GOALS)". Stanford GOALS is a large-scale, community-based randomized controlled trial of an innovative, interdisciplinary, multi-component, multi-level, multi-setting (MMM) approach to treating overweight and obese children. Primary Research Question: Will a 3-year, innovative, interdisciplinary, multi-compo...
What is the current status of trial NCT01642836?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2012-07-13. Estimated completion is 2016-12-19.
What interventions are being tested in trial NCT01642836?
The interventions under investigation include: MMM (BEHAVIORAL), Health and Nutrition Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01642836?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01642836's enrollment target sits among peer trials
241 440th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI